V-Bio Ventures logo

V-Bio Ventures

Europe, Oost-Vlaanderen, Belgium, Gent

Description

V-Bio Ventures finds, builds and finances young, innovative companies with ambitions in the life sciences arena.

Investor Profile

V-Bio Ventures has made 32 investments, with 6 in the past 12 months and 34% as lead.

Stage Focus

  • Series A (56%)
  • Series B (22%)
  • Seed (16%)
  • Series C (3%)
  • Undisclosed (3%)

Country Focus

  • Belgium (69%)
  • France (13%)
  • United Kingdom (9%)
  • The Netherlands (3%)
  • Italy (3%)
  • Denmark (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Agriculture
  • Biopharma
  • Chemical
  • Life Science
  • Agtech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does V-Bio Ventures frequently co-invest with?

AdBio partners
Europe, Ile-de-France, France, Paris
Co-Investments: 5
Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 6
Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 8
AI
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 5
VIB
Europe, Oost-Vlaanderen, Belgium, Gent
Co-Investments: 13
Qbic Fund
North America, Wisconsin, United States, Belgium
Co-Investments: 4
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 5
Vives Louvain Technology Fund
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 5
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 5
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 10

What are some of recent deals done by V-Bio Ventures?

Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
ATB Therapeutics

Aye, Luxembourg, Belgium

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

BiotechnologyHealth CareTherapeutics
Series ANov 18, 2024
Amount Raised: $57,210,541
Confo Therapeutics

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.

BiotechnologyHealth CareMedicalTherapeutics
Series BJul 26, 2024
Amount Raised: $65,148,419
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AJun 26, 2024
Amount Raised: $18,206,938
Biodol Therapeutics

Clapiers, Languedoc-Roussillon, France

Biodol Therapeutics made a breakthrough discovery on the origin and maintenance of NP.

Therapeutics
UndisclosedMay 21, 2024
Amount Raised: $7,597,902
Flindr Therapeutics

Amsterdam, Noord-Holland, The Netherlands

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

BiotechnologyHealth CareTherapeutics
Series AApr 24, 2024
Amount Raised: $21,400,056
Protealis

Gent, Oost-Vlaanderen, Belgium

Sustainable plant proteins for Europe​

AgricultureAgTechBiotechnology
Series BJan 23, 2024
Amount Raised: $23,886,612
Tanai Therapeutics

Gent, Oost-Vlaanderen, Belgium

Therapeutics for obesity and obesity-related conditions.

Health CareLife ScienceTherapeutics
SeedDec 6, 2023
Corteria Pharmaceuticals

Paris, Ile-de-France, France

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

BiotechnologyPharmaceuticalTherapeutics
Series ASep 7, 2023
Amount Raised: $69,538,574
Aphea.Bio

Zwijnaarde, Oost-Vlaanderen, Belgium

Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.

AgricultureBiotechnologyChemical
Series CJul 11, 2023
Amount Raised: $77,099,644